Design Therapeutics launches with $45m to develop a new class of disease-modifying therapies for serious degenerative disorders

Design Therapeutics launches with $45m to develop a new class of disease-modifying therapies for serious degenerative disorders. (Credit: PublicDomainPictures from Pixabay)